Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection

• We developed a two-session behavioral intervention to prevent HCV reinfection. • The intervention was piloted at an OTP and integrated into HCV treatment. • Baseline data showed limited knowledge & application of safer injection practices. • Implementation barriers included logistics and the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Viera, Adam, Grau, Lauretta E., Fisher, Jeffrey D., Farnum, Scott O., Tetrault, Jeanette M., Scott, Greg, Heimer, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948939/
https://www.ncbi.nlm.nih.gov/pubmed/36845980
http://dx.doi.org/10.1016/j.dadr.2022.100038
_version_ 1784892881236918272
author Viera, Adam
Grau, Lauretta E.
Fisher, Jeffrey D.
Farnum, Scott O.
Tetrault, Jeanette M.
Scott, Greg
Heimer, Robert
author_facet Viera, Adam
Grau, Lauretta E.
Fisher, Jeffrey D.
Farnum, Scott O.
Tetrault, Jeanette M.
Scott, Greg
Heimer, Robert
author_sort Viera, Adam
collection PubMed
description • We developed a two-session behavioral intervention to prevent HCV reinfection. • The intervention was piloted at an OTP and integrated into HCV treatment. • Baseline data showed limited knowledge & application of safer injection practices. • Implementation barriers included logistics and the lack of financial incentive. • Adaptations addressed barriers, yielding a more feasible and acceptable intervention.
format Online
Article
Text
id pubmed-9948939
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99489392023-02-23 Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection Viera, Adam Grau, Lauretta E. Fisher, Jeffrey D. Farnum, Scott O. Tetrault, Jeanette M. Scott, Greg Heimer, Robert Drug Alcohol Depend Rep Short Communication • We developed a two-session behavioral intervention to prevent HCV reinfection. • The intervention was piloted at an OTP and integrated into HCV treatment. • Baseline data showed limited knowledge & application of safer injection practices. • Implementation barriers included logistics and the lack of financial incentive. • Adaptations addressed barriers, yielding a more feasible and acceptable intervention. Elsevier 2022-03-11 /pmc/articles/PMC9948939/ /pubmed/36845980 http://dx.doi.org/10.1016/j.dadr.2022.100038 Text en © 2022 The Authors. Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Short Communication
Viera, Adam
Grau, Lauretta E.
Fisher, Jeffrey D.
Farnum, Scott O.
Tetrault, Jeanette M.
Scott, Greg
Heimer, Robert
Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection
title Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection
title_full Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection
title_fullStr Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection
title_full_unstemmed Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection
title_short Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection
title_sort development and pilot-testing of a hepatitis c reinfection prevention intervention for patients in treatment for hepatitis c infection
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948939/
https://www.ncbi.nlm.nih.gov/pubmed/36845980
http://dx.doi.org/10.1016/j.dadr.2022.100038
work_keys_str_mv AT vieraadam developmentandpilottestingofahepatitiscreinfectionpreventioninterventionforpatientsintreatmentforhepatitiscinfection
AT graulaurettae developmentandpilottestingofahepatitiscreinfectionpreventioninterventionforpatientsintreatmentforhepatitiscinfection
AT fisherjeffreyd developmentandpilottestingofahepatitiscreinfectionpreventioninterventionforpatientsintreatmentforhepatitiscinfection
AT farnumscotto developmentandpilottestingofahepatitiscreinfectionpreventioninterventionforpatientsintreatmentforhepatitiscinfection
AT tetraultjeanettem developmentandpilottestingofahepatitiscreinfectionpreventioninterventionforpatientsintreatmentforhepatitiscinfection
AT scottgreg developmentandpilottestingofahepatitiscreinfectionpreventioninterventionforpatientsintreatmentforhepatitiscinfection
AT heimerrobert developmentandpilottestingofahepatitiscreinfectionpreventioninterventionforpatientsintreatmentforhepatitiscinfection

Ejemplares similares